Eli Lilly and Company News
Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact
Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.
Cramer's Mad Money Recap 6/15: Powell Crushes it
Jim Cramer says the Fed action is great news for high-growth tech stocks, which should be among the first sectors to recover.
Cramer's Mad Money Recap 6/7: Target, Smucker, Eli Lilly
Jim Cramer says smart investing is as simple as buying growth stocks when interest rates begin to fall.
Stock Market Today - 6/6: Dow Ends Slightly Higher as Treasury Yields Top 3%; Amazon Gains After 20-for-1 Split
Solid jobs and manufacturing data are prompting bets on a so-called 'Goldilocks' outcome for U.S. stocks as the Fed looks to tame inflation without choking-off growth.
Eli Lilly Stock Gains On Impressive Data From Jardiance Diabetes Drug Trial
"These five-year results ... showing empagliflozin was associated with a decreased risk of hospitalization for heart failure and for death, are encouraging data for adults with type 2 diabetes," said co-lead investigator Dr. Elisabetta Patorno.
Breaking News
Tesla Stock Slips Lower After Q2 Delivery Slump, Planned Factory Closures
Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.
Exxon Stock Jumps On Bets For Record Q2 Profits Amid Global Oil Price Surge
"High energy prices are largely a result of underinvestment by many in the energy industry over the last several years and especially during the pandemic," Exxon said.
Summers, Others Cite Growing Chance of Recession
GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.
Coinbase Faces A New Scandal
The platform denies selling proprietary customer data and announces it is expanding into several European countries.